Header cover image

Brazilian Pharmaceuticals & Biotech High And Sustainable

Results

1

1 new

Companies in a sound financial shape with a dividend yield of more than 5%.

1 companies

Hypera

Market Cap: R$14.9b

Operates as a pharmaceutical company in Brazil.

New

HYPE3

R$21.16

7D

-1.4%

1Y

-7.7%